A Study Investigating the Clinical and Metabolic Benefits of Dapagliflozin plus Saxagliptin Combination in Type-II Diabetes Mellitus (T2D) Patients
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2019
Price : $35 *
At a glance
- Drugs Dapagliflozin/saxagliptin (Primary) ; Dapagliflozin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association.
- 22 Jul 2018 New trial record
- 26 Jun 2018 Results presented at the 78th Annual Scientific Sessions of the American Diabetes Association.